Back to RecallTracker
Health Canada Health products

Antipsychotic drugs: Labelling update regarding the risk of abnormal muscle movements and withdrawal symptoms in newborns exposed during pregnancy

Issued June 15, 2011
Issue
Hazard description
New safety information